1. California Opioid Hub and Spokes Project
DHCS
Marlies Perez, State Project Director
Michael Freeman, Project Manager; Kevin Masuda, Project Analyst
CA H&SS
Implementation Team
UCLA
Richard Rawson, Principal Investigator
Mark McGovern (Stanford), Learning Collaboratives
Thomas Freese, Training/Technical Assistance
Gloria Miele, Learning Collaborative Coordinator
Beth Rutkowski, Training Liaison
Training Coordinator and assistants
Consultants
John Brooklyn
Tony Folland
Barbara Cimaglio
Regional CA Addiction and Primary Care MDs
Evaluation Team
Darren Urada, Principal Investigator
Vandana Joshi, Co-Investigator
Howard Padwa, Co-Investigator
Data Collection Coordinator and assistants
Advisors
Betsy Hall
Yih-Ing Hser
Lynn Brecht
UCLA
Program Director
Valerie Antonini
Advisory Group Implementation & Evaluation experts, H&SS participants, community members, DHCS representatives, CSAM, CHCF
CSAM
Kerry Parker, Jean Marsters, MD, Steve Eickelberg, MD
CHCF
Kelly Pfeifer, MD

2. California Opioid Hub and Spokes Project Implementation Activities
Implementation Team
UCLA
Chair: Richard Rawson; Co-Leader: Valerie Antonini
Learning Collaboratives: Mark McGovern, Gloria Miele
Purpose: Engage H&SS participants in process of shared learning and experience to facilitate implementation of services, assist with procedural changes, and provide opportunities for interactive problem solving.
Activities: Conduct Regional Quarterly LC meetings
Training and Technical Assistance: Thomas Freese, Gloria Miele, UCLA Trainers
Purpose: Meet training and technical assistance needs of H&SS participants through just-in-time training including online self paced courses, in person and online training.
Activities: Bi-annual Best Practices conferences, Bi-annual Clinical Skills trainings, Quarterly community-wide MAT training, and ongoing assistance with additional resources.
Consultants
Consultants will be available to provide additional technical assistance including:
John Brooklyn, Tony Folland, Barbara Cimaglio, Kelly Pfeifer/CHCF, and California Addiction and Primary Care MDs.
CSAM
Jean Marsters, MD, Steven Eickelberg, MD, Kerry Parker
Purpose: Provide support to providers in spokes to build confidence in prescribing
Activities: Four-day mentored learning experiences for approximately 60 spoke participants who will attend the CSAM Annual Conference in August 2018 in San Francisco; updating of the Guideline for Physicians Working in CA Opioid Treatment Programs published in 2009; and two CSAM educational webinars

3. The National Opioid Crisis

4. Overdose Deaths per 100,000
New York Times:

5. Overdose Deaths per 100,000
New York Times:

6. Overdose Deaths per 100,000
New York Times:

7. Drug overdose deaths in 2016 most likely exceeded 59,000, the largest annual jump ever recorded in the United States, according to preliminary data compiled by The New York Times.

8. Vermont Data

9. New England Drug Overdose Deaths
Drug Overdose Data. Source: Deaths per 100,000
Includes all drug overdoses, not just opioids.
During 2015, drug overdoses accounted for 52,404 U.S. deaths, including 33,091 (63.1%) that involved an opioid.
Source: CDC/NCHS, National Vital Statistics System, mortality data. Includes opioids and other drugs 
Vermont Department of Health

10. New England Drug Overdose Deaths
Drug Overdose Data. Source: Deaths per 100,000
Includes all drug overdoses, not just opioids.
During 2015, drug overdoses accounted for 52,404 U.S. deaths, including 33,091 (63.1%) that involved an opioid.
Source: CDC/NCHS, National Vital Statistics System, mortality data. Includes opioids and other drugs 
Vermont Department of Health

11. The number of individuals using heroin at treatment admission has increased in the last five years
Source: Alcohol and Drug Abuse Treatment Programs

12. Rate of Past Year Opioid Abuse or Dependence
Rate of Past Year Opioid Abuse or Dependence* and Rate of Medication Assisted Treatment Capacity with Methadone or Buprenorphine
Source: NSDUH
Original Data:
Am J Public Health August; 105(8): e55–e63.
Published online 2015 August.doi:   /AJPH
PMCID: PMC
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
Christopher M. Jones, PharmD, MPH, Melinda Campopiano, MD, Grant Baldwin, PhD, MPH, and Elinore McCance-Katz, MD, PhD
More information:
Source: N-SSATS
*Opioid abuse or dependence includes prescription opioids and/or heroin
Source: AJPH 2015; 105(8):e55-63
Vermont Department of Health